Non-sleepy obstructive sleep apnoea: to treat or not to treat?
Yükleniyor...
Dosyalar
Tarih
2019
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
European Respiratory Soc Journals Ltd
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Non-sleepy obstructive sleep apnoea (OSA) is thought to have a prevalence of around 20-25% in industrialised countries. However, the question of whether it should be routinely treated or not is controversial. This review collates the results from recent randomised controlled trials addressing OSA and examines whether treating the condition leads to improvements in quality of life and reduced cardiometabolic dysfunction, comorbidities generally attributed to untreated obstructive sleep apnoea/hypopnoea syndrome.
Açıklama
Anahtar Kelimeler
Positive Airway Pressure, Excessive Daytime Sleepiness, Artery-Disease Patients, Long-Term Use, To-Severe Osa, Blood-Pressure, Insulin-Resistance, Cardiovascular Outcomes, Asymptomatic Patients, Cpap Therapy
Kaynak
European Respiratory Review
WoS Q Değeri
Q1
Scopus Q Değeri
Q1
Cilt
28
Sayı
154
